GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Open Access
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 146, 112582
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82100473)
- Natural Science Foundation of Hubei Province (2015CFB316)
- Natural Science Foundation of Hubei Province (2019CFB549)
This publication has 131 references indexed in Scilit:
- GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosisEuropean Journal of Medical Research, 2013
- Growth Differentiation Factor‐15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin‐6–Dependent Inflammatory Response to Vascular InjuryJournal of the American Heart Association, 2012
- The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive PatientsPLOS ONE, 2012
- Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older AdultsCirculation, 2011
- Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxisJournal of Experimental Medicine, 2011
- Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesisJournal of Cell Biology, 2010
- Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular DevelopmentThe American Journal of Pathology, 2010
- Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With NephropathyDiabetes Care, 2010
- The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiationNature Cell Biology, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003